Sage Journals: Discover world-class research

Abstract

Cochrane has developed a linked data infrastructure to make the evidence and data from its rich repositories more discoverable to facilitate evidence-based health decision-making. These annotated resources can enhance the study and understanding of biomarkers and surrogate endpoints.

Get full access to this article

View all access options for this article.

References

See <https://linkeddata.cochrane.org/> (last visited July 9, 2019).

Effective Practice and Organization of Care Group and Public Health, see <https://www.cochrane.org/about-us/our-global-community/review-group-networks> (last visited July 9, 2019).

See <https://www.cochranelibrary.com/central/about-central> (last visited July 9, 2019).

See <https://linkeddata.cochrane.org/pico-ontology> (last visited July 9, 2019).

See <https://www.nature.com/articles/sdata201618> (last visited July 9, 2019).

A. L.

Sampson ,

R. F.

Singer , and

G. D.

Walters , “Uric Acid Lowering Therapies for Preventing or Delaying the Progression of Chronic Kidney Disease,” Cochrane Database of Systematic Reviews 10 (2017): Art. No.: CD009460, doi: 10.1002/14651858.CD009460.pub2.

N. A.

Graudal ,

Hubeck-Graudal , and

Jurgens , “Effects of Low Sodium Diet Versus High Sodium Diet on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterol, and Triglyceride,” Cochrane Database of Systematic Reviews 4 (2017): Art. No.: CD004022, doi: 10.1002/14651858.CD004022.pub4.

Schuetz ,

Wirz ,

Sager , et al., “Procalcitonin to Initiate or Discontinue Antibiotics in Acute Respiratory Rract Infections,” Cochrane Database of Systematic Reviews 10 (2017): Art. No.: CD007498, doi: 10.1002/14651858.CD007498.pub3.

T. M.

Marteau ,

D. P.

French ,

S. J.

Griffin

et al., “Effects of Communicating DNA-Based Disease Risk Estimates on Risk-Reducing Hehaviours,” Cochrane Database of Systematic Reviews 10 (2010): Art. No.: CD007275, doi: 10.1002/14651858.CD007275.pub2.

10.

K. W.

Southern ,

Patel ,

I. P.

Sinha , and

S. J.

Nevitt , “Correctors (Specific Therapies for Class II CFTR Mutations) for Cystic Fibrosis,” Cochrane Database of Systematic Reviews 8 (2018): Art. No.: CD010966, doi: 10.1002/14651858.CD010966.pub2.

11.

Schuit ,

O. A.

Panagiotou ,

M. R.

Munafò , et al., “Pharmaco-therapy for Smoking Cessation: Effects by Subgroup Defined by Genetically Informed Biomarkers,” Cochrane Database of Systematic Reviews 9 (2017): Art. No.: CD011823, doi: 10.1002/14651858.CD011823.pub2.

12.

Aabenhus ,

J. U. S.

Jensen ,

K. J.

Jørgensen

et al., “Biomarkers as Point-of-Care Tests to Guide Prescription of Antibiotics in Patients with Acute Respiratory Infections in Primary Care,” Cochrane Database of Systematic Reviews 11 (2014): Art. No.: CD010130, doi: 10.1002/14651858.CD010130.pub2.

13.

H. L.

Petsky ,

C. J.

Cates ,

Li , et al., “Tailored Interventions Based on Exhaled Nitric Oxide Versus Clinical Symptoms for Asthma in Children and Adults,” Cochrane Database of Systematic Reviews 4 (2009): Art. No.: CD006340, doi: 10.1002/14651858.CD006340.pub3.

14.

S. K.

Alldred ,

Takwoingi ,

Guo , et al., “First Trimester Ultrasound Tests Alone or in Combination with First Trimester Serum Tests for Down's Syndrome Screening,” Cochrane Database of Systematic Reviews 3 (2017): Art. No.: CD012600, doi: 10.1002/14651858.CD012600;

Rompianesi ,

Hann ,

Komolafe , et al., “Serum Amylase and Lipase and Urinary Trypsinogen and Amylase for Diagnosis of Acute Pancreatitis,” Cochrane Database of Systematic Reviews 4 (2017): Art. No.: CD012010, doi: 10.1002/14651858.CD012010.pub2;

Gupta ,

M. L.

Hull ,

Fraser , et al., “Endometrial Biomarkers for the Non-Invasive Diagnosis of Endometriosis,” Cochrane Database of Systematic Reviews 4 (2016); Art. No.: CD012165. doi: 10.1002/14651858.CD012165;

Shaikh ,

J. L.

Borrell ,

Evron , and

M. M. G.

Leeflang , “Procalcitonin, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Diagnosis of Acute Pyelonephritis in Children,” Cochrane Database of Systematic Reviews 1 (2015): Art. No.: CD009185. doi: 10.1002/14651858.CD009185.pub2.

15.

See <https://doi.org/10.1002/14651858.CD011798.pub2> (last visited July 17, 2019).

16.

See <https://doi.org/10.1002/14651858.CD006161.pub3> (last visited July 17, 2019).

17.

See <https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ucm613636.htm> (last visited July 17, 2019).

18.

S. P.

Hey

et al., “Challenges and Opportunities for Biomarker Validation,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 357-361;

Shrager ,

Shapiro , and

Hoos , “Is Cancer Solvable? Towards Efficient and Ethical Biomedical Science,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 326-368;

Li and

Sim , “How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 369-373;

S.P.

Hey

et al., “Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 381-387;

L. M.

McShane

, “Biomarker Validation: Context and Complexities,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 388-392;

A.D.

Zhang and

J. S.

Ross , “Biomarkers as Surrogate Endpoints: Ongoing Opportunities for Validation,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 393-395;

A. D.

Stern

, “Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures,” Journal of Law, Medicine & Ethics 47, no. 3 (2019): 396-397.

Cochrane's Linked Data Project: How it Can Advance our Understanding of Surrogate Endpoints

Abstract

Get full access to this article

References